The WTO and India's Pharmaceuticals Industry: Patent Protection, TRIPS, and Developing Countries

Sudip Chaudhuri

161 citations0/0 files stored

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Intellectual Property Law Intellectual Property and Patents

Abstract

INTRODUCTION NATIONAL PATENTS, INDUSTRIAL POLICY, AND RISE AND GROWTH OF THE PHARMACEUTICAL INDUSTRY IN INDIA GLOBALIZATION OF PATENT LAWS: FLEXIBILITIES UNDER TRIPS AND CHANGES IN PHARMACEUTICAL PATENTS IN INDIA PATENT REGIME AND ROLE OF MNCS IN THE PHARMACEUTICAL INDUSTRY IN INDIA TRIPS AND R&D FOR NEGLECTED DISEASES GROWTH AND PROSPECTS OF GENERIC PHARMACEUTICAL EXPORTS FROM INDIA TRIPS AND AFFORDABILITY AND ACCESSIBILITY OF PHARMACEUTICAL PRODUCTS DRUG PRICE CONTROL: INDIA'S EXPERIENCE AND FUTURE PROSPECTS SHOULD DEVELOPING COUNTRIES PROVIDE PATENT PROTECTION IN PHARMACEUTICAL PRODUCTS? BIBLIOGRAPHY INDEX

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 161 citations exist upstream.

Cited by

2007The Political Economy of AIDS Treatment: Intellectual Property and the Transformation of Generic Supply 2019Patents, trade and medicines: past, present and future 2019Resurgent Asia 2010Mergers, Acquisitions and Firms’ Performance: Experience of Indian Pharmaceutical Industry 2021Global value chains, import orientation, and the state: South Africa’s pharmaceutical industry 2015Board Characteristics, Financial Slack and R&D Investments 2009The Changing Governance Structures of the Global Pharmaceutical Value Chain 2012A co-evolutionary perspective on the drivers of international sourcing of pharmaceutical R&D to India

Imported from OpenAlex (CC0) — nothing here is generated.